Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study.

Conflating odds ratio with "risk". BMJ (2014) 0.97

Using clinically relevant measures of risk. BMJ (2014) 0.95

Causes and consequences of coagulation activation in sepsis: an evolutionary medicine perspective. BMC Med (2015) 0.78

The effect of sepsis and its inflammatory response on mechanical clot characteristics: a prospective observational study. Intensive Care Med (2016) 0.77

Antigen Presentation After Stroke. Neurotherapeutics (2016) 0.76

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model. Arterioscler Thromb Vasc Biol (2015) 0.76

Longitudinal Study of the Effects of Bacteremia and Sepsis on 5-year Risk of Cardiovascular Events. Clin Infect Dis (2016) 0.75

Preoperative sepsis and postoperative thrombosis. BMJ (2014) 0.75

Author's reply to Wong and De Murtinho-Braga. BMJ (2014) 0.75

Concurrent bariatric operations and association with perioperative outcomes: registry based cohort study. BMJ (2017) 0.75

Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest (1992) 47.46

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56

Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52

Progress and challenges in translating the biology of atherosclerosis. Nature (2011) 9.41

Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation (1999) 8.17

Chronic infections and coronary heart disease: is there a link? Lancet (1997) 7.18

Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med (1992) 5.65

A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med (2009) 4.46

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.30

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22

Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet (1997) 2.66

The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med (1993) 2.41

Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet (1998) 2.39

Infection and atherosclerosis: emerging mechanistic paradigms. Circulation (1999) 2.23

Thrombosis risk assessment as a guide to quality patient care. Dis Mon (2005) 2.13

Inflammation and infections as risk factors for ischemic stroke. Stroke (2003) 2.12

Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. Lancet (1996) 1.97

Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA (1995) 1.78

Evaluating interventions with differential attrition: the importance of nonresponse mechanisms and use of follow-up data. J Appl Psychol (1993) 1.77

Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA (2005) 1.70

Venous and arterial thromboembolism in severe sepsis. Thromb Haemost (2008) 1.50

High risk of the critically ill for venous thromboembolism. Crit Care Med (1982) 1.45

Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol (2013) 1.39

Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis (1998) 1.27

Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg (2007) 1.26

Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis. Thromb Haemost (2009) 1.16

Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ (2000) 1.15

Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost (1991) 1.09

Infection and risk of ischemic stroke: differences among stroke subtypes. Stroke (2003) 1.06

An international prospective cohort study evaluating major vascular complications among patients undergoing noncardiac surgery: the VISION Pilot Study. Open Med (2011) 0.92

Prevention of pulmonary emboli in a respiratory intensive care unit: efficacy of low-dose heparin. Chest (1981) 0.89